Michael Moore - 17 Jan 2026 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
President
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol
VMD
Transactions as of
17 Jan 2026
Net transactions value
-$112,024
Form type
4
Filing time
21 Jan 2026, 17:02:33 UTC
Previous filing
13 Aug 2025
Next filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moore Michael President 625 E. KALISTE SALOOM RD., LAFAYETTE /s/ Jesse Bergeron, Attorney-in-Fact 21 Jan 2026 0001781905

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +26,939 +21% 153,282 17 Jan 2026 Direct F1
transaction VMD Common Shares Tax liability $62,657 -8,548 -5.6% $7.33 144,734 17 Jan 2026 Direct F2, F3
transaction VMD Common Shares Options Exercise +6,735 +4.7% 151,469 17 Jan 2026 Direct F4
transaction VMD Common Shares Disposed to Issuer $49,368 -6,735 -4.4% $7.33 144,734 17 Jan 2026 Direct F3
holding VMD Common Shares 1,722,614 17 Jan 2026 by Moore Faster LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Restricted Stock Units Options Exercise $0 -26,939 -100% $0.000000 0 17 Jan 2026 Common Shares 26,939 Direct F1, F5
transaction VMD Phantom Share Units Options Exercise -6,735 -100% 0 17 Jan 2026 Common Shares 6,735 Direct F4, F6
transaction VMD Restricted Stock Units Award $0 +118,759 $0.000000 118,759 19 Jan 2026 Common Shares 118,759 Direct F1, F7
transaction VMD Phantom Share Units Award $0 +29,690 $0.000000 29,690 19 Jan 2026 Common Shares 29,690 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F2 Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F3 Per share value is based on the market closing price of the common shares for January 16, 2026.
F4 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5 Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F6 Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7 Restricted Stock Units (RSUs) granted to reporting person on January 19, 2026, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F8 Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
F9 Represents an award granted on January 19, 2026 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.